Skip to main content
Caplight Logo









U-Earth Biotech Ltd.

U-Earth Biotech Ltd.

Private
LondonEnergy & Sustainabilityhttps://u-earth.eu

Last Round

Early Funding

Nov 18, 2020

Momentum

Top 25%

of companies Caplight tracks

Company Overview

U-Earth Biotech Ltd. is a biotechnology and environmental engineering company that provides air purification solutions using a proprietary system of bioreactors to attract and digest airborne contaminants.

Sector

Energy & Sustainability

Verticals

Biotechnology, Environmental Monitoring, Smart Buildings, D2C Brands

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

bioreactor air purifiercommercial air purificationclean air as a serviceair quality monitoringbiotech air purifierair quality as a servicenature-based solutionPure Air ZoneairtechcleantechESG reportingIoT sensorsAQaaSproptechfacility management techair purification subscriptionbiotechnologyreusable face maskbiotech skincare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

U-Earth Biotech Ltd. Comparables

Compare U-Earth Biotech Ltd. with similar companies based on industry and business-model similarity.

U-Earth Biotech Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Clean Air Zone Inc.
81%
Aura Smart Air
78%
Naava
77%

U-Earth Biotech Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingNov 18, 2020

Key People

Founding team and executive leadership

Betta Maggio

Founder And CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased from 0 to 2, representing 29% of headcount.

  • Jan 26, 2026

    Monthly visitors grew 72% MoM.

U-Earth Biotech Ltd. Filings

Explore SEC and related filing metadata, where available.

U-Earth Biotech Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about U-Earth Biotech Ltd.'s valuation, stock price, and market status.

Is U-Earth Biotech Ltd. a public or private company?

U-Earth Biotech Ltd. is a private company.

What is the current stock price of U-Earth Biotech Ltd.?

U-Earth Biotech Ltd. is a private company, so its shares have no public market price. Caplight tracks U-Earth Biotech Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is U-Earth Biotech Ltd. worth (valuation)?

Valuation information for U-Earth Biotech Ltd. is not publicly available.

Can I buy U-Earth Biotech Ltd. stock?

U-Earth Biotech Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was U-Earth Biotech Ltd.'s last funding round?

U-Earth Biotech Ltd.'s most recent funding round was Early Funding on November 18, 2020.

Who are the main investors in U-Earth Biotech Ltd.?

Investor information for U-Earth Biotech Ltd. is not publicly disclosed.

Will U-Earth Biotech Ltd. IPO soon?

No public IPO plans have been announced for U-Earth Biotech Ltd..

How can I track U-Earth Biotech Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in U-Earth Biotech Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range7
Year Founded2018
Last FundingNov 18, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?